Validated QPS Assays
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno-bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
Search For An Assay Here
Perindopril
Perindoprilat
Perindoprilat
Matrix: | Human Plasma |
Assay Range: | 1.00 - 200 ng/mL 0.400 - 40.0 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC-MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Perindoprilat
Matrix: | Human Plasma |
Assay Range: | 0.1 - 20 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Perphenazine
Matrix: | Human Plasma |
Assay Range: | 0.02 - 2 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antipsychotic |
Classification: | Drug Assays |
Phenobarbital
Matrix: | Human Plasma |
Assay Range: | 5 - 5,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Sedative |
Classification: | Drug Assays |
PIGF
Matrix: | Human Serum |
Assay Range: | 1.00 - 30.0 pg/mL |
Sample Volume: | 0.4 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | ELISA |
Site: | QPS-NL |
CLIA: | |
Therapy Area: | |
Classification: | Biochemical Biomarkers |
PIK3CA (1634A>G, 1636C>A, 1633G>A, 1624G>A, 3129G>T, 3139C>T, 3140A>T, 3140A>G) Genotyping
Matrix: | Human Whole Blood |
Assay Range: | N.Ap. |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -80 |
Platform: | Pyrosequencing |
Site: | QPS-Delaware |
CLIA: | |
Therapy Area: | |
Classification: | Genomic Biomarkers |
Pimavanserin
Matrix: | Human Plasma |
Assay Range: | 0.1 - 50 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC-MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antipsychotic |
Classification: | Drug Assays |
Pitavastatin
Matrix: | Human Plasma |
Assay Range: | 0.2 - 200 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC-MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Pitavastatin
Matrix: | Human Plasma |
Assay Range: | 2 - 200 ng/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Pitavastatin
Matrix: | Human Plasma |
Assay Range: | 0.5 - 100 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Placenta Growth Factor (PIGF)
Matrix: | Human Serum |
Assay Range: | 1.00 - 30.0 pg/mL |
Sample Volume: | 0.4 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | ELISA |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Posaconazole
Matrix: | Human Plasma |
Assay Range: | 0.5 - 500 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antifungal |
Classification: | Drug Assays |
Posaconazole
Matrix: | Human Plasma |
Assay Range: | 2 - 650 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | |
Therapy Area: | |
Classification: | Drug Assays |
Posaconazole
Matrix: | Human Plasma |
Assay Range: | 2.5 - 900 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antifungal |
Classification: | Drug Assays |
Pramipexole
Matrix: | Human Plasma |
Assay Range: | 5 - 500 pg/mL |
Sample Volume: | 0.4 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Parkinson's Disease |
Classification: | Drug Assays |
Pramipexole
Matrix: | Human Plasma |
Assay Range: | 20.0 - 20,000 pg/mL |
Sample Volume: | 0.200 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC-MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Parkinson's Disease |
Classification: | Drug Assays |
Pramipexole
Matrix: | Human Plasma |
Assay Range: | 20 - 2,000 pg/mL |
Sample Volume: | 0.5 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Parkinson's Disease |
Classification: | Drug Assays |
Pravastatin
Matrix: | Human Plasma |
Assay Range: | 1 - 300 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Pravastatin
Matrix: | Human Plasma |
Assay Range: | 0.25 - 100 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Pravastatin
Matrix: | Human Plasma |
Assay Range: | 1.00-300 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | |
Platform: | LC-MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Pravastatin
Rosuvastatin
Rosuvastatin
Matrix: | Human Urine |
Assay Range: | 1 - 1,000 ng/mL 0.3 - 300 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | NA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Prednisolone (free fraction)
Cortisol (free freaction)
Cortisol (free freaction)
Matrix: | Human Serum |
Assay Range: | 1.00 - 500 ng/mL 5.00 - 500 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | LC-MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Antiinflammatory |
Classification: | Drug Assays |
Prednisolone
Cortisol
Cortisol
Matrix: | Human Serum |
Assay Range: | 2.50 - 500 ng/mL 5.00 - 500 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | LC-MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Antiinflammatory |
Classification: | Drug Assays |
Prednisone
Matrix: | Human Plasma |
Assay Range: | 0.3 - 30 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Antiinflammatory |
Classification: | Drug Assays |
Prednisone
Matrix: | Human Plasma |
Assay Range: | 0.5 - 180 ng/mL |
Sample Volume: | 0.5 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antiinflammatory |
Classification: | Drug Assays |
Links to Relevant Documents
Testimonials
Thanks for the good news, I’m happy to see that within less than a month you will have developed and validated the assay. Good Job!
QPS CLIENT